Northeast India’s Only English and Hindi Satellite News Channel

Covaxin

Banner
India’s Omicron tally crosses 700 mark, Delhi tops the list

India’s Omicron cases tally has crossed the 700 mark leading to fresh restrictions in multiple states and union territories. Currently, India’s Omicron tally stands at 717 cases. Yesterday the country saw an increase in 46 Omicron cases which has led to the present tally. Fresh cases have come in from 20 states of which the […]

9 months ago
Banner

#NorthEast Live Team

Govt to formulate policy on vaccination for children, booster doses for adults within 2 weeks

  The National Technical Advisory Group on Immunisation in India (NTAGI) is slated to meet in the coming two weeks to discuss the crucial issue of COVID-19 vaccination for children in India.  It is also supposed to plan for COVID-19 boosted does for adults.  Importantly COVID-19 vaccination for children is one of the several important […]

10 months ago
Banner

#Northeast Live Web Desk

136 cr doses of Covishield, Covaxin to lead India’s COVID-19 vaccination programme between Aug-Dec

More than 136 crore COVID-19 vaccine doses are expected to be available till the end of this year, informed the Centre. For the next four months, India’s vaccine programme will be accelerated by the Serum Institute of India’s (SII) Covishield and Bharat Biotech’s Covaxin. The note titled “Covid-19 Public Health Response Pro-active, Pre-emptive and Graded […]

1 year ago
Banner

#Northeast Live Web Desk

COVID-19: Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc

Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19. It also added that Covaxin gives 65.2 per cent protection against the SARS-CoV-2, B.1.617.2 Delta variant. “Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against […]

1 year ago
Banner

#Northeast Live Web Desk

Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials, say sources

Bharat Biotech’s Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources. The Hyderabad-based COVID vaccine manufacturing company had submitted data from the Phase III clinical trials of Covaxin to the Drugs Controller General of India (DCGI) […]

1 year ago
Banner

#Northeast Live Web Desk

Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre’s Covaxin price

Indigenous COVID-19 vaccine maker Bharat Biotech on Tuesday said the supply price of Covaxin to the Government of India at Rs 150 per dose is a non-competitive price and not sustainable in the long run, hence a higher price in private markets is required to offset part of the costs. “The supply price of Covaxin […]

1 year ago
Banner

#Northeast Live Web Desk

AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials from tomorrow onwards: Sources

The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech’s Covaxin is scheduled to start from Tuesday. According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine. […]

1 year ago
Banner

#Northeast Live Web Desk

Bharat Biotech shares full data of all research studies of Covaxin

Bharat Biotech on Saturday shared full data of all research studies of its Covaxin – India’s first indigenous COVID-19 vaccine. As per the company officials, the complete data for Phase I and II, and partial data for Phase III trials of Covaxin have been thoroughly scrutinised by the regulators in India. In a timely approach […]

1 year ago
Banner

#Northeast Live Web Desk

Centre places orders for 25 crore doses of Covishield, 19 crore Covaxin doses

The Union Health Ministry on Tuesday informed that the Centre has placed an order to purchase 25 crores doses of Covishield and 19 crore doses of Covaxin. “The Union Health Ministry has placed an order with Serum Institute of India for 25 crore doses of Covishield and with Bharat Biotech for 19 crore doses of […]

1 year ago
Banner

#Northeast Live Web Desk

Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday. “Covaxin has been approved by the Drugs Controller General of India (DCGI), for […]

1 year ago